ID

14580

Beschreibung

Real-Life Evidence on Stroke Prevention in SPAF; ODM derived from: https://clinicaltrials.gov/show/NCT02485873

Link

https://clinicaltrials.gov/show/NCT02485873

Stichworte

  1. 22.04.16 22.04.16 -
Hochgeladen am

22. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Atrial Fibrillation (Prevention of Stroke) NCT02485873

Eligibility Atrial Fibrillation (Prevention of Stroke) NCT02485873

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥18 years on the day of the first prescription of the study drug (= index date) during study selection window
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of nvaf on start date of study or anytime during 365 days before this date
Beschreibung

Atrial Fibrillation | Heart Valves

Datentyp

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2]
C0018826
availability of follow-up at least 180 days after the date of the first prescription of study drug within selection window of study (exposure start date)
Beschreibung

Availability of follow-up | Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C1522577
UMLS CUI [2]
C0013230
evidence of patient activity in the database during 90 days before the date of the first prescription of target drug within selection window.
Beschreibung

Evidence of Patient activity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332120
UMLS CUI [1,2]
C0451369
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with valvular af
Beschreibung

Atrial Fibrillation | Heart Valves

Datentyp

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2]
C0018826
prescriptions of oral anticoagulants (oacs: vka, dabigatran, rivaroxaban) before index date
Beschreibung

oral anticoagulants | Vitamin K antagonists | dabigatran | rivaroxaban

Datentyp

boolean

Alias
UMLS CUI [1]
C0354604
UMLS CUI [2]
C3653316
UMLS CUI [3]
C2348066
UMLS CUI [4]
C1739768
prescription of more than one oac on the index date or switch to another oac during the follow-up period
Beschreibung

Other oral anticoagulants

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0354604
prescriptions of < 15mg rivaroxaban at index date or during the follow-up period for patients in rivaroxaban cohort
Beschreibung

rivaroxaban | cohort

Datentyp

boolean

Alias
UMLS CUI [1]
C1739768
UMLS CUI [2]
C0599755

Ähnliche Modelle

Eligibility Atrial Fibrillation (Prevention of Stroke) NCT02485873

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age ≥18 years on the day of the first prescription of the study drug (= index date) during study selection window
boolean
C0001779 (UMLS CUI [1])
Atrial Fibrillation | Heart Valves
Item
diagnosis of nvaf on start date of study or anytime during 365 days before this date
boolean
C0004238 (UMLS CUI [1])
C0018826 (UMLS CUI [2])
Availability of follow-up | Investigational New Drugs
Item
availability of follow-up at least 180 days after the date of the first prescription of study drug within selection window of study (exposure start date)
boolean
C0470187 (UMLS CUI [1,1])
C1522577 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2])
Evidence of Patient activity
Item
evidence of patient activity in the database during 90 days before the date of the first prescription of target drug within selection window.
boolean
C0332120 (UMLS CUI [1,1])
C0451369 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Atrial Fibrillation | Heart Valves
Item
patients with valvular af
boolean
C0004238 (UMLS CUI [1])
C0018826 (UMLS CUI [2])
oral anticoagulants | Vitamin K antagonists | dabigatran | rivaroxaban
Item
prescriptions of oral anticoagulants (oacs: vka, dabigatran, rivaroxaban) before index date
boolean
C0354604 (UMLS CUI [1])
C3653316 (UMLS CUI [2])
C2348066 (UMLS CUI [3])
C1739768 (UMLS CUI [4])
Other oral anticoagulants
Item
prescription of more than one oac on the index date or switch to another oac during the follow-up period
boolean
C0205394 (UMLS CUI [1,1])
C0354604 (UMLS CUI [1,2])
rivaroxaban | cohort
Item
prescriptions of < 15mg rivaroxaban at index date or during the follow-up period for patients in rivaroxaban cohort
boolean
C1739768 (UMLS CUI [1])
C0599755 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video